While there are no HIV or Herpes vaccines approved for use in 2024, the U.S. National Institute of Allergy and Infectious Diseases recently awarded $537,310 to fund a Mechanisms Underlying the HIV-HSV-2 Syndemic study.
These sexually transmitted diseases are co-present in millions of individuals within the United States.
Read More
